多参数前列腺MRI结构化报告中前瞻性纳入表观扩散系数:鉴别临床无显著意义与有显著意义前列腺癌
这项单中心研究纳入218例3-T多参数前列腺MRI异常(PI-RADS v2评分≥3)且后续根治性前列腺切除或靶向活检阳性的男性,由9名放射科医生之一前瞻性报告每个病灶的平均ADC值,评估其鉴别ISUP 1级与ISUP 2-5级前列腺癌的诊断效能。结果显示ISUP 2-5级病灶平均ADC值低于ISUP 1级,外周带AUC为0.91、移行带为0.70,最佳截断值外周带0.682、移行带0.638(×10-3 mm²/s),对应敏感度和特异度分别为78%和94%、72%和67%。
要点
- 在临床解读中前瞻性报告的病灶平均ADC值有助于鉴别临床无显著意义与有显著意义前列腺癌。
- 外周带ISUP 2-5级病灶平均ADC值0.597 vs ISUP 1级0.855(×10-3 mm²/s),差异有统计学意义(p<0.0001)。
- 移行带ISUP 2-5级病灶平均ADC值0.600 vs ISUP 1级0.660(×10-3 mm²/s),差异有统计学意义(p=0.035)。
核心结论
- 在临床环境中前瞻性估算的ADC值可帮助鉴别临床无显著意义与有显著意义前列腺癌,有助于活检前和治疗前风险分层。
研究设计与样本
- 单中心研究,纳入218例3-T多参数前列腺MRI异常(PI-RADS v2评分≥3)且后续根治性前列腺切除或靶向活检阳性的男性;由9名放射科医生之一在临床解读时前瞻性报告每个病灶的平均ADC值;以靶向活检或全标本病理分析中部位一致的病灶作为参考标准;采用逻辑回归评估平均ADC值鉴别ISUP 1级与2-5级的效用,并以ROC AUC评估诊断效能。
诊断标准与关键数值
- ADC≤0.700×10-3 mm²/s的病灶被标记为可疑临床有显著意义前列腺癌;ISUP 2-5级病灶平均ADC值低于ISUP 1级:总体0.598 vs 0.803(×10-3 mm²/s,p<0.0001),外周带0.597 vs 0.855(×10-3 mm²/s,p<0.0001),移行带0.600 vs 0.660(×10-3 mm²/s,p=0.035);外周带AUC为0.91,移行带AUC为0.70;最佳ADC截断值外周带0.682×10-3 mm²/s、移行带0.638×10-3 mm²/s,对应敏感度和特异度外周带78%和94%、移行带72%和67%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study was to assess the diagnostic performance of prospectively assigned mean apparent diffusion coefficient (ADC) values in multiparametric MRI (mpMRI) structured reports for discriminating clinically insignificant (International Society of Urological Pathology [ISUP] group 1) from clinically significant (ISUP groups 2-5) prostate cancer.
MATERIALS AND METHODS: This single-center study included men with abnormal 3-T mpMRI findings (Prostate Imaging Reporting and Data System version 2 score, ≥ 3) who subsequently underwent radical prostatectomy or targeted biopsy with positive results. One of nine radiologists prospectively reported the mean ADC for each lesion during clinical interpretation. Lesions with ADC ≤ 0.700 mm2/s × 10-3 were flagged as concerning for clinically significant prostate cancer. The index lesion at MRI correlated with the site-concordant lesion at targeted biopsy or whole-mount histopathologic analysis. Logistic regression was used to evaluate the utility of mean ADC values for discriminating ISUP grade group 1 from groups 2-5. Diagnostic performance was assessed by ROC AUC.
RESULTS: Among the 218 eligible men, those with ISUP group 2-5 lesions had lower mean ADC values than those with ISUP 1 lesions; overall, 0.598 vs 0.803 mm/s2 × 10-3 (p < 0.0001); peripheral zone (PZ), 0.597 vs 0.855 mm/s2 × 10-3 (p < 0.0001); transition zone (TZ), 0.600 vs 0.660 mm/s2 × 10-3 (p = 0.035). The AUC for the PZ was 0.91 and for the TZ was 0.70. The optimal ADC cutoff values were 0.682 mm/s2 × 10-3 for PZ lesions and 0.638 mm2/s × 10-3 for TZ lesions, resulting in sensitivity and specificity of 78% and 94% for the PZ and 72% and 67% for the TZ.
CONCLUSION: ADC values estimated prospectively in a clinical setting can help differentiate clinically insignificant from clinically significant prostate cancer, facilitating prebiopsy and pretreatment risk stratification.
引用
- Costa DN, Xi Y, Aziz M, et al. Prospective Inclusion of Apparent Diffusion Coefficients in Multiparametric Prostate MRI Structured Reports: Discrimination of Clinically Insignificant and Significant Cancers. AJR Am J Roentgenol. 2018. PMID: 30383404. doi:10.2214/AJR.18.19937
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。